radar-logo-white

Becton Dickinson EMEA

Organization details

Area of expertise:​
Antimicrobial susceptibility testing Data management Decision support for smart AMR management Detection system for MDROs – after culture Detection system for MDROs – direct from sample Information and communication systems Integrated solution for rapid detection and smart AMR management and control Molecular detection of MDROs Open platform Other Point of care testing Rapid identification of microorganisms Smart AMR management and control systems Use of AI in smart AMR management
Company type:​
Private company
Seeking for:​
Antimicrobial susceptibility testing Data management Decision support for smart AMR management Detection system for MDROs - after culture Detection system for MDROs - direct from sample Detection system to differentiate virus from bacteria Information and communication systems Integrated solution for rapid detection and smart AMR management and control Molecular detection of MDROs Point of care testing Rapid identification of microorganisms Smart AMR management and control systems Supply chain integration Use of AI in smart AMR management
Organization size:

More than 250

Headquarters country:

United States

Website:

Contact

Contact person:

Claudio Palmieri

Email:

claudio.palmieri@bd.com

BD is one of the largest global medical technology companies in the world and is advancing the world of healthTM by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of healthcare by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for healthcare providers. BD and its 75,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians’ care delivery process, enable laboratory scientists to accurately detect disease and advance researchers’ capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to healthcare.

The BD Life Sciences segment delivers innovative solutions from discovery to diagnosis, continually advancing science and clinical outcomes across infectious disease and cancer. Offerings include preanalytical solutions for sample management; immunology research solutions, including flow cytometry and multiomics tools; microbiology and molecular diagnostics; lab automation and informatics solutions; and differentiated reagents and assays.

Seeking (additional informations)